Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?

Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The...

Descripció completa

Dades bibliogràfiques
Autors principals: Montserrat Viñas-Bastart, Míriam Oms-Arias, Àfrica Pedraza-Gutiérrez, Irene Lizano-Díez, Eduardo L. Mariño, Pilar Modamio Charles
Format: Article
Idioma:English
Publicat: Fundación Pharmaceutical Care España 2022-06-01
Col·lecció:Pharmaceutical Care España
Matèries:
Accés en línia:https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/680